Findings represent some of the first data on pneumococcal conjugate vaccine (PCV) impact in Asia and are important for other countries with a high burden of childhood pneumonia and pneumococcal disease.

This website uses cookies to improve your experience, as described in our privacy policy.
Click “accept” to consent to use of cookies and similar technologies while on our site.